“Here we show that the main psychoactive cannabinoid, Δ-9-tetrahydrocannabinol (THC), and the main nonpsychoactive cannabinoid, cannabidiol (CBD), markedly reduce the Th17 phenotype which is known to be increased in inflammatory autoimmune pathologies such as Multiple Sclerosis.”
Kozela, E., Juknat, A., Kaushansky, N., Rimmerman, N., Ben-Nun, A., & Vogel, Z. (2013). Cannabinoids Decrease the Th17 Inflammatory Autoimmune Phenotype. Journal of NeuroImmune Pharmacology, 8(5), 1265-1276.